Literature DB >> 7723593

Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents.

H Yamaya1, Y Basaki, M Togawa, M Kojima, M Kiniwa, N Matsuura.   

Abstract

Local eosinophilia has been linked to the pathogenesis of the inflammatory aspect of allergic diseases. The present study found that co-injection of D10G4.1 (D10) cells, a murine Th2 clone, with conalbumin (CA) into the peritoneal cavity of AKR/J mice increased the number of peritoneal eosinophils. The accumulation of eosinophils reached a maximum level at 24 to 48 hr and was accompanied by a marked increase in the number of neutrophils and a minor increase in the number of mononuclear cells. D10-induced peritoneal eosinophilia was suppressed by administration of either anti-IL-4 and anti-IL-5 monoclonal antibodies in an additive manner or by cyclosporin A (CsA). Interestingly, suplatast tosilate (IPD-1151T), known to be antiallergic agent capable of suppressing IgE synthesis and chemical mediator release, but not disodium cromoglycate, selectively suppressed eosinophil accumulation. Taken together with the observation that CsA and IPD-1151T suppressed IL-4 and IL-5 production by CA-stimulated D10 cells in vitro, the present results strongly suggest that agents capable of down-regulating Th2 cell cytokine production may attenuate allergic inflammation by impairing the recruitment of eosinophils that is mediated by Th2 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723593     DOI: 10.1016/0024-3205(95)00132-p

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  A preliminary study of PEFR monitoring in patients with chronic cough.

Authors:  T Sano; H Ueda; H Bando
Journal:  Lung       Date:  2004       Impact factor: 2.584

Review 2.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

3.  Usefulness of suplatast tosilate for chronic cough following lung cancer surgery.

Authors:  Hideaki Miyamoto; Yukinori Sakao; Motoki Sakuraba; Shiaki Oh; Nobumasa Takahashi; Yoshikazu Miyasaka; Tomoya Inagaki; Taku Akaboshi; Enjo Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-13

4.  Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.

Authors:  T Sano; Y Nakamura; H Yanagawa; H Bando; A Nii; S Yoshida; S Sone
Journal:  Lung       Date:  2003       Impact factor: 2.584

5.  Case of eosinophilic cystitis treated with suplatast tosilate as maintenance therapy.

Authors:  Tateki Yoshino; Hiroyuki Moriyama
Journal:  Case Rep Urol       Date:  2012-09-11

6.  Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.

Authors:  M Kurokawa; K Kawazu; K Asano; K Fumio; A Mita; M Adachi
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.